Voyager Therapeutics (VYGR) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to $68.7 million.
- Voyager Therapeutics' Non-Current Assets rose 3066.28% to $68.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $387.2 million, marking a year-over-year increase of 9428.16%. This contributed to the annual value of $116.2 million for FY2024, which is 26788.62% up from last year.
- Latest data reveals that Voyager Therapeutics reported Non-Current Assets of $68.7 million as of Q3 2025, which was up 3066.28% from $94.2 million recorded in Q2 2025.
- Over the past 5 years, Voyager Therapeutics' Non-Current Assets peaked at $116.2 million during Q4 2024, and registered a low of $31.6 million during Q4 2023.
- In the last 5 years, Voyager Therapeutics' Non-Current Assets had a median value of $54.7 million in 2024 and averaged $57.1 million.
- Per our database at Business Quant, Voyager Therapeutics' Non-Current Assets plummeted by 3932.39% in 2022 and then soared by 26788.62% in 2024.
- Voyager Therapeutics' Non-Current Assets (Quarter) stood at $57.2 million in 2021, then crashed by 39.02% to $34.9 million in 2022, then dropped by 9.35% to $31.6 million in 2023, then skyrocketed by 267.89% to $116.2 million in 2024, then crashed by 40.88% to $68.7 million in 2025.
- Its Non-Current Assets stands at $68.7 million for Q3 2025, versus $94.2 million for Q2 2025 and $108.0 million for Q1 2025.